These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32942298)

  • 1. Association of the Obesity Paradox With Objective Physical Activity in Patients at High Risk of Sudden Cardiac Death.
    Li X; Chen K; Hua W; Su Y; Yang J; Liang Z; Xu W; Xue X; Zhang S; Zhao S
    J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32942298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response association of implantable device-measured physical activity with long-term cardiac death and all-cause mortality in patients at high risk of sudden cardiac death: a cohort study.
    Li X; Zhao S; Chen K; Hua W; Su Y; Yang J; Liang Z; Xu W; Zhang S
    Int J Behav Nutr Phys Act; 2020 Sep; 17(1):119. PubMed ID: 32957993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable device measured objective daily physical activity as a predictor of long-term all-cause mortality and cardiac death in patients with age > 75 years and high risk of sudden cardiac death: a cohort study : Physical activity and patients over 75 years old.
    Li X; Chen K; Hua W; Su Y; Yang J; Liang Z; Xu W; Zhao S; Li Z; Zhang S
    BMC Geriatr; 2022 Feb; 22(1):130. PubMed ID: 35172757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.
    Fumagalli C; Maurizi N; Day SM; Ashley EA; Michels M; Colan SD; Jacoby D; Marchionni N; Vincent-Tompkins J; Ho CY; Olivotto I;
    JAMA Cardiol; 2020 Jan; 5(1):65-72. PubMed ID: 31693057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between patient activity and long-term cardiac death in patients with implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators.
    Zhao S; Chen K; Su Y; Hua W; Chen S; Liang Z; Xu W; Dai Y; Liu Z; Fan X; Hou C; Zhang S
    Eur J Prev Cardiol; 2017 May; 24(7):760-767. PubMed ID: 28117620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body mass index and outcomes of cardiac resynchronization with implantable cardioverter-defibrillator therapy in older patients with heart failure.
    Echouffo-Tcheugui JB; Masoudi FA; Bao H; Curtis JP; Heidenreich PA; Fonarow GC
    Eur J Heart Fail; 2019 Sep; 21(9):1093-1102. PubMed ID: 31359595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overweight and obesity as protective factors against mortality in nonischemic cardiomyopathy patients with an implantable cardioverter defibrillator.
    Zhou B; Zhao S; Tang M; Chen K; Hua W; Su Y; Chen S; Liang Z; Xu W; Li X; Xue X; Sun X; Zhang S
    Clin Cardiol; 2020 Dec; 43(12):1435-1442. PubMed ID: 32936479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body mass index and risk of adverse cardiac events in elderly patients with hip fracture: a population-based study.
    Batsis JA; Huddleston JM; Melton LJ; Huddleston PM; Lopez-Jimenez F; Larson DR; Gullerud RE; McMahon MM
    J Am Geriatr Soc; 2009 Mar; 57(3):419-26. PubMed ID: 19175436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only.
    Palmisano P; Accogli M; Pisanò EC; Zaccaria M; De Blasi S; Ponzetta MA; Valsecchi S; Milanese G; Lauretti M; Magliari F
    Europace; 2016 Sep; 18(9):1374-82. PubMed ID: 26612878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.
    Au-Yeung WT; Reinhall PG; Poole JE; Anderson J; Johnson G; Fletcher RD; Moore HJ; Mark DB; Lee KL; Bardy GH
    Heart Rhythm; 2015 Oct; 12(10):2058-66. PubMed ID: 26096609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
    Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M;
    Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body Mass Index and Sudden Cardiac Death in Japanese Patients After Acute Myocardial Infarction: Data From the JCAD Study and HIJAMI-II Registry.
    Shiga T; Kohro T; Yamasaki H; Aonuma K; Suzuki A; Ogawa H; Hagiwara N; Yamazaki T; Nagai R; Kasanuki H
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 29982233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators.
    Bilchick KC; Wang Y; Cheng A; Curtis JP; Dharmarajan K; Stukenborg GJ; Shadman R; Anand I; Lund LH; Dahlström U; Sartipy U; Maggioni A; Swedberg K; O'Conner C; Levy WC
    J Am Coll Cardiol; 2017 May; 69(21):2606-2618. PubMed ID: 28545633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gender-paradox among patients with implantable cardioverter-defibrillators: a propensity-matched study.
    Bhavnani SP; Pavuluri V; Coleman CI; Guertin D; Yarlagadda RK; Clyne CA; Kluger J
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):878-84. PubMed ID: 23614760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cardiac resynchronization therapy-defibrillator implantation on the association between body mass index and prognosis in patients with heart failure.
    Yanagisawa S; Inden Y; Shimano M; Yoshida N; Ishikawa S; Kato H; Okumura S; Miyoshi-Fujii A; Nagao T; Yamamoto T; Mizutani Y; Ito T; Hirai M; Murohara T
    J Interv Card Electrophysiol; 2015 Sep; 43(3):269-77. PubMed ID: 26003807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter-defibrillators in end-stage heart failure patients listed for heart transplantation: Results from a large retrospective registry.
    Gandjbakhch E; Rovani M; Varnous S; Maupain C; Chastre T; Waintraub X; Pousset F; Lebreton G; Duthoit G; Badenco N; Himbert C; Leprince P; Hidden-Lucet F
    Arch Cardiovasc Dis; 2016; 109(8-9):476-85. PubMed ID: 27344378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation.
    Sweeney MO; Ruskin JN; Garan H; McGovern BA; Guy ML; Torchiana DF; Vlahakes GJ; Newell JB; Semigran MJ; Dec GW
    Circulation; 1995 Dec; 92(11):3273-81. PubMed ID: 7586314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of body mass index on survival after sudden cardiac arrest.
    Matinrazm S; Ladejobi A; Pasupula DK; Javed A; Durrani A; Ahmad S; Munir MB; Adelstein E; Jain SK; Saba S
    Clin Cardiol; 2018 Jan; 41(1):46-50. PubMed ID: 29355997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac implantable electronic devices with a defibrillator component and all-cause mortality in left ventricular assist device carriers: results from the PCHF-VAD registry.
    Cikes M; Jakus N; Claggett B; Brugts JJ; Timmermans P; Pouleur AC; Rubis P; Van Craenenbroeck EM; Gaizauskas E; Grundmann S; Paolillo S; Barge-Caballero E; D'Amario D; Gkouziouta A; Planinc I; Veenis JF; Jacquet LM; Houard L; Holcman K; Gigase A; Rega F; Rucinskas K; Adamopoulos S; Agostoni P; Biocina B; Gasparovic H; Lund LH; Flammer AJ; Metra M; Milicic D; Ruschitzka F;
    Eur J Heart Fail; 2019 Sep; 21(9):1129-1141. PubMed ID: 31410955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.
    Marijon E; Trinquart L; Otmani A; Waintraub X; Kacet S; Clémenty J; Chatellier G; Le Heuzey JY;
    Am Heart J; 2009 Feb; 157(2):391-397.e1. PubMed ID: 19185651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.